TBI Overview2020-02-26T19:50:32+00:00


BioDirection exhibiting at this year’s 2019 MEDICA Conference in Düsseldorf, Germany

BioDirection is excited to be exhibiting at this year’s 2019 MEDICA Conference in Düsseldorf, Germany!

Please visit us on November 18th – 21st in Hall 3, Booth C36-4 to learn more about BioDirection’s Tbit™ System that uses a hand-held analyzer and single-use cartridge to deliver real-time, point-of-care diagnosis of traumatic brain injury in 90 seconds from a single drop of blood. The BioDirection Tbit™ System is currently for investigational use only. Visit us online at http://biodirection.com/

About NanoDx, Inc.

NanoDx, Inc., is a privately held medical device company developing breakthrough, point-of-care diagnostic solutions that address unmet market needs and improve patient outcomes while reducing healthcare costs. The company's flagship product, the NanoDx System, is capable of detecting and quantifying biomarkers (analytes) from a small fluid specimen in less than 2 minutes. NanoDx's platform utilizes a proprietary nanosensor technology with a broad range of potential diagnostic applications including COVID-19, Traumatic Brain Injury (TBI), Influenza, Sepsis and Stroke. www.NanoDiagnostics.com

Mike Sampson
Chief Commercial Officer
Tel: +1 508.599.2400
Email: msampson@nanodiagnostics.com